Form 4 for LH Labcorp
Accepted 2026-06-10 09:01:40 ET · period of report 2026-06-08 · accession 0000920148-26-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-10 09:01 | 2026-06-08 | LH | Kyle Kathryn W | EVP, CLO | S - Sale | $263.89 | -762 | 3,813 | -17% | -$201.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-08 | S | D | 762 | $263.89 | 3,813.46 | D | — | — | (F1) Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |